Skip to main content

Table 2 Data on endoscopic treatment

From: The use of fully covered self-expandable metal stents in the endoscopic treatment of portal cavernoma cholangiopathy

Parameters

n = 12

Cholangiography findings (n)

Strictures

 ♣ Common bile duct

 ♣ Common hepatic duct

 ♣ Left intra-hepatic ducts

 ♣ Right intra-hepatic ducts

12

12

2

0

Gallstone(s)

 ♣ Choledocholithiasis

 ♣ Hepatolithiasis

4

2

Time to stent removal

6 weeks

12 weeks

8

4

Balloon dilatation

6

Removal of biliary stones

6

Success rate of FCSEMS placement

100%

ALP before initial ERC

328 (420 − 229) U/L

ALP after SEMS placement

128 (144 − 112) U/L

Total bilirubin before initial ERC

5.9 (8.4–3.6) mg/dL

Total bilirubin after SEMS placement

1.2(2.1–0.9) mg/dL

Complication (n)

Post-ERC abdominal pain

Acute cholecystitis

 • Percutaneous cholecystostomy

 • Medical treatment

Bleeding

 • Portal vein cannulation

8

7

2

5

1

1

Recurrence (n)

2